From: Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
Cohort
TNM stage
Immune infiltrating score + TNM stage
P-value
c-index
95% CI
Training cohort
0.619
0.594–0.643
0.686
0.659–0.714
< 0.001
Validation cohort
0.661
0.621–0.700
0.695
0.650–0.740